Published in Cancer Weekly, October 22nd, 2002
Individuals with colorectal cancer often face the risk of their cancer cells migrating to the liver. Researchers in the Netherlands have advised that combining standard chemotherapy with proteins that prevent tumor neovascularization can reduce tumor involvement and increase survival in murine models of early colorectal liver metastasis.
In the animal model study, E.A. te Velde and colleagues, University Medical Center...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.